Benzimidazoles, pharmaceutical compositions containing these compounds
and processes for preparing them
    5.
    发明授权
    Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them 失效
    苯并咪唑,含有这些化合物的药物组合物及其制备方法

    公开(公告)号:US5521177A

    公开(公告)日:1996-05-28

    申请号:US132065

    申请日:1993-10-04

    CPC分类号: C07D403/10 C07D235/08

    摘要: The invention relates to benzimidazoles of general formula ##STR1## Exemplary compounds are: (a) 4'-[[2-Ethyl-4-methyl-6-[(2-dimethylamino-3,4-dioxo-1-cyclobuten-1-yl)amino]-1H-benzimidazol-1-yl]-methyl]-2-(1H-tetrazol-5-yl)-biphenyl,(b) 4'-[[2-n-Propyl-4-methyl-6-(2-cyano-3,3-dimethyl-guanidino)-1H-benzimidazol-1-yl]-methyl]-2-(1H-tetrazol-5-yl)-biphenyl,(c) 4'-[[2-n-Propyl-4-methyl-6-(2,2-dicyano-1-dimethylamino-etheneamino)-1H-benzimidazol -1-yl]-methyl]-2-(1H-tetrazol-5-yl)-biphenyl,(d) 4'-[[2-n-Propyl-4-methyl-6-(1-morpholino-2-nitro-etheneamino)-1H-benzimidazol -1 -yl]-methyl]-2-(1H-tetrazol-5-yl)-biphenyl, and(e) 4'-[[2-n-Propyl-4-methyl-6-(1,1-dimethylamino-2-nitro-etheneamino)-1H-benzimidazol -1-yl]-methyl]-2-(1H-tetrazol-5-yl)-biphenyl.The new compounds are angiotensin-antagonists.

    摘要翻译: 本发明涉及通式(I)的苯并咪唑:(I)示例性化合物是:(a)4' - [[2-乙基-4-甲基-6 - [(2-二甲基氨基-3,4-二氧代-1- 环丁烯-1-基)氨基] -1H-苯并咪唑-1-基] - 甲基] -2-(1H-四唑-5-基) - 联苯,(b)4' - [[2-正丙基-4- (2-氰基-3,3-二甲基 - 胍基)-1H-苯并咪唑-1-基] - 甲基] -2-(1H-四唑-5-基) - 联苯,(c)4 ' - [[2-正丙基-4-甲基-6-(2,2-二氰基-1-二甲基氨基 - 乙烯基氨基)-1H-苯并咪唑-1-基] - 甲基] -2-(1H-四唑 - (d)4' - [[2-正丙基-4-甲基-6-(1-吗啉代-2-硝基 - 乙烯基氨基)-1H-苯并咪唑-1-基]甲基 ] -2-(1H-四唑-5-基) - 联苯,和(e)4' - [[2-正丙基-4-甲基-6-(1,1-二甲基氨基-2-硝基 - 乙烯基氨基) -1H-苯并咪唑-1-基] - 甲基] -2-(1H-四唑-5-基) - 联苯。 新化合物是血管紧张素拮抗剂。